Given the mounting evidence of the possible involvement of single heterozygous ATP7B mutations in phenotypes with parkinsonism (Table S10), it can be speculated that p.H1069Q mutation in our CBS-NAV patient has led to the subclinical dysregulation of copper metabolism. This evidence concerns the gene ATP7B and Parkinson disease.